Latest Articles

Publication Date
From Ovarian to Endometrial Cancer, Experts Spotlight Standout Data From ASCO 2026 - OncLive

From Ovarian to Endometrial Cancer, Experts Spotlight Standout Data From ASCO 2026 OncLive

Published: June 15, 2026, 12:06 p.m.
Ovarian Cancer: The silent killer women don’t talk about - THIP Media

Ovarian Cancer: The silent killer women don’t talk about THIP Media

Published: June 15, 2026, 9:06 a.m.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - The Manila Times

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 The Manila Times

Published: June 14, 2026, 10:21 p.m.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - NTB Kommunikasjon

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 NTB Kommunikasjon

Published: June 14, 2026, 10:05 p.m.
Endometrial Cancer, Sri Lanka’s Commonest Gynaecological Cancer - dailynews.lk

Endometrial Cancer, Sri Lanka’s Commonest Gynaecological Cancer dailynews.lk

Published: June 14, 2026, 7:42 p.m.
Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data - TipRanks

Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data TipRanks

Published: June 11, 2026, 4:35 p.m.
Bulletin: GLP-1RAs Help Reduce Obesity Related Cancers - Medical News Bulletin

Bulletin: GLP-1RAs Help Reduce Obesity Related Cancers Medical News Bulletin

Published: June 11, 2026, 2:44 p.m.
GLP-1 RAs Help Reduce Obesity Related Cancers - Medical News Bulletin

GLP-1 RAs Help Reduce Obesity Related Cancers Medical News Bulletin

Published: June 11, 2026, 2:37 p.m.
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies - The Malaysian Reserve

Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies The Malaysian Reserve

Published: June 11, 2026, 6:33 a.m.
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies - StreetInsider

Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies StreetInsider

Published: June 11, 2026, 5:42 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!